References
- Kim WY, Kaelin WG. Role of VHL gene mutation in human cancer. J Clin Oncol 2004; 22:4991 - 5004; http://dx.doi.org/10.1200/JCO.2004.05.061; PMID: 15611513
- Kaelin WG. Von Hippel-Lindau disease. Annu Rev Pathol 2007; 2:145 - 73; http://dx.doi.org/10.1146/annurev.pathol.2.010506.092049; PMID: 18039096
- Haase VH. The VHL tumor suppressor in development and disease: functional studies in mice by conditional gene targeting. Semin Cell Dev Biol 2005; 16:564 - 74; http://dx.doi.org/10.1016/j.semcdb.2005.03.006; PMID: 15908240
- Semenza GL. Hypoxia-inducible factor 1 (HIF-1) pathway. Sci STKE 2007; 2007:cm8; http://dx.doi.org/10.1126/stke.4072007cm8; PMID: 17925579
- Kaelin WG Jr., Ratcliffe PJ. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell 2008; 30:393 - 402; http://dx.doi.org/10.1016/j.molcel.2008.04.009; PMID: 18498744
- Haase VH. The VHL tumor suppressor: master regulator of HIF. Curr Pharm Des 2009; 15:3895 - 903; http://dx.doi.org/10.2174/138161209789649394; PMID: 19671042
- Li M, Kim WY. Two sides to every story: the HIF-dependent and HIF-independent functions of pVHL. J Cell Mol Med 2011; 15:187 - 95; http://dx.doi.org/10.1111/j.1582-4934.2010.01238.x; PMID: 21155973
- Ohh M, Yauch RL, Lonergan KM, Whaley JM, Stemmer-Rachamimov AO, Louis DN, et al. The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix. Mol Cell 1998; 1:959 - 68; http://dx.doi.org/10.1016/S1097-2765(00)80096-9; PMID: 9651579
- Tang N, Mack F, Haase VH, Simon MC, Johnson RS. pVHL function is essential for endothelial extracellular matrix deposition. Mol Cell Biol 2006; 26:2519 - 30; http://dx.doi.org/10.1128/MCB.26.7.2519-2530.2006; PMID: 16537898
- Hergovich A, Lisztwan J, Barry R, Ballschmieter P, Krek W. Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL. Nat Cell Biol 2003; 5:64 - 70; http://dx.doi.org/10.1038/ncb899; PMID: 12510195
- Thoma CR, Frew IJ, Hoerner CR, Montani M, Moch H, Krek W. pVHL and GSK3beta are components of a primary cilium-maintenance signalling network. Nat Cell Biol 2007; 9:588 - 95; http://dx.doi.org/10.1038/ncb1579; PMID: 17450132
- O’regan L, Blot J, Fry AM. Mitotic regulation by NIMA-related kinases. Cell Div 2007; 2:25; http://dx.doi.org/10.1186/1747-1028-2-25; PMID: 17727698
- White MC, Quarmby LM. The NIMA-family kinase, Nek1 affects the stability of centrosomes and ciliogenesis. BMC Cell Biol 2008; 9:29; http://dx.doi.org/10.1186/1471-2121-9-29; PMID: 18533026
- Moniz L, Dutt P, Haider N, Stambolic V. Nek family of kinases in cell cycle, checkpoint control and cancer. Cell Div 2011; 6:18; http://dx.doi.org/10.1186/1747-1028-6-18; PMID: 22040655
- Natoli TA, Gareski TC, Dackowski WR, Smith L, Bukanov NO, Russo RJ, et al. Pkd1 and Nek8 mutations affect cell-cell adhesion and cilia in cysts formed in kidney organ cultures.. Am J Physiol Renal Physiol 2008; 294:F73 - 83; http://dx.doi.org/10.1152/ajprenal.00362.2007; PMID: 17928412
- Chen Y, Chen PL, Chen CF, Jiang X, Riley DJ. Never-in-mitosis related kinase 1 functions in DNA damage response and checkpoint control. Cell Cycle 2008; 7:3194 - 201; http://dx.doi.org/10.4161/cc.7.20.6815; PMID: 18843199
- Chen Y, Chen CF, Riley DJ, Chen PL. Nek1 kinase functions in DNA damage response and checkpoint control through a pathway independent of ATM and ATR. Cell Cycle 2011; 10:655 - 63; http://dx.doi.org/10.4161/cc.10.4.14814; PMID: 21301226
- Upadhya P, Birkenmeier EH, Birkenmeier CS, Barker JE. Mutations in a NIMA-related kinase gene, Nek1, cause pleiotropic effects including a progressive polycystic kidney disease in mice. Proc Natl Acad Sci USA 2000; 97:217 - 21; http://dx.doi.org/10.1073/pnas.97.1.217; PMID: 10618398
- Thiel C, Kessler K, Giessl A, Dimmler A, Shalev SA, von der Haar S, et al. NEK1 mutations cause short-rib polydactyly syndrome type majewski. Am J Hum Genet 2011; 88:106 - 14; http://dx.doi.org/10.1016/j.ajhg.2010.12.004; PMID: 21211617
- Shalom O, Shalva N, Altschuler Y, Motro B. The mammalian Nek1 kinase is involved in primary cilium formation. FEBS Lett 2008; 582:1465 - 70; http://dx.doi.org/10.1016/j.febslet.2008.03.036; PMID: 18387364
- Schoenfeld AR, Davidowitz EJ, Burk RD. Elongin BC complex prevents degradation of von Hippel-Lindau tumor suppressor gene products. Proc Natl Acad Sci USA 2000; 97:8507 - 12; http://dx.doi.org/10.1073/pnas.97.15.8507; PMID: 10900011
- Mohan S, Burk RD. von Hippel-Lindau protein complex is regulated by cell density. Oncogene 2003; 22:5270 - 80; http://dx.doi.org/10.1038/sj.onc.1206592; PMID: 12917628
- Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999; 399:271 - 5; http://dx.doi.org/10.1038/20459; PMID: 10353251
- Esteban MA, Harten SK, Tran MG, Maxwell PH. Formation of primary cilia in the renal epithelium is regulated by the von Hippel-Lindau tumor suppressor protein. J Am Soc Nephrol 2006; 17:1801 - 6; http://dx.doi.org/10.1681/ASN.2006020181; PMID: 16775032
- Ampofo E, Kietzmann T, Zimmer A, Jakupovic M, Montenarh M, Götz C. Phosphorylation of the von Hippel-Lindau protein (VHL) by protein kinase CK2 reduces its protein stability and affects p53 and HIF-1alpha mediated transcription. Int J Biochem Cell Biol 2010; 42:1729 - 35; http://dx.doi.org/10.1016/j.biocel.2010.07.008; PMID: 20637892
- Roe JS, Kim HR, Hwang IY, Ha NC, Kim ST, Cho EJ, et al. Phosphorylation of von Hippel-Lindau protein by checkpoint kinase 2 regulates p53 transactivation. Cell Cycle 2011; 10:3920 - 8; http://dx.doi.org/10.4161/cc.10.22.18096; PMID: 22071692
- Lolkema MP, Gervais ML, Snijckers CM, Hill RP, Giles RH, Voest EE, et al. Tumor suppression by the von Hippel-Lindau protein requires phosphorylation of the acidic domain. J Biol Chem 2005; 280:22205 - 11; http://dx.doi.org/10.1074/jbc.M503220200; PMID: 15824109
- Hergovich A, Lisztwan J, Thoma CR, Wirbelauer C, Barry RE, Krek W. Priming-dependent phosphorylation and regulation of the tumor suppressor pVHL by glycogen synthase kinase 3. Mol Cell Biol 2006; 26:5784 - 96; http://dx.doi.org/10.1128/MCB.00232-06; PMID: 16847331
- Jiang M, Liu K, Luo J, Dong Z. Autophagy is a renoprotective mechanism during in vitro hypoxia and in vivo ischemia-reperfusion injury. Am J Pathol 2010; 176:1181 - 92; http://dx.doi.org/10.2353/ajpath.2010.090594; PMID: 20075199
- Pabla N, Ma Z, McIlhatton MA, Fishel R, Dong Z. hMSH2 recruits ATR to DNA damage sites for activation during DNA damage-induced apoptosis. J Biol Chem 2011; 286:10411 - 8; http://dx.doi.org/10.1074/jbc.M110.210989; PMID: 21285353
- Plotnikova OV, Pugacheva EN, Golemis EA. Primary cilia and the cell cycle. Methods Cell Biol 2009; 94:137 - 60; http://dx.doi.org/10.1016/S0091-679X(08)94007-3; PMID: 20362089